GSDMB and myeloid sarcoma: Building on our identification of the significant knowledge gaps surrounding these molecules, future studies should specifically address: Could GSDMB variants, previously associated with multiple sclerosis (MS), also be implicated in MS‐related peripheral neuropathies?